Sasisopin Kiertiburanakul
Biographic Data
| ID | 8935869 |
|---|---|
| NAME | Sasisopin Kiertiburanakul |
| GIVEN NAMES | Sasisopin |
| FAMILY NAME | Kiertiburanakul |
| SIGNATURE | KIERTIBURANAKUL S |
| AFFILIATIONS | Mahidol University |
| ORCID | 0000-0003-4379-4704 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2018 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Lingering sex and age disparities in dolutegravir uptake among adults with HIV
INTRODUCTION: Since July 2019, the WHO has recommended dolutegravir (DTG)-based regimens as preferred first-line antiretroviral therapy (ART) for adults and adolescents living with HIV (DTG-for-All), a reversal of a 2018 safety alert on use of DTG-based regimens by women of reproductive age (WRA). We examined sex and age disparities in DTG uptake before and after DTG-for-All in the International epidemiology Databases to Evaluate AIDS. METHODS: W…
Early suboptimal ART adherence was associated with missed clinical visits in HIV-infected patients in Asia
Missed clinic visits can lead to poorer treatment outcomes in HIV-infected patients. Suboptimal antiretroviral therapy (ART) adherence has been linked to subsequent missed visits. Knowing the determinants of missed visits in Asian patients will allow for appropriate counselling and intervention strategies to ensure continuous engagement in care. A missed visit was defined as having no assessments within six months. Repeated measures logistic regr…
No prominent works on this page.
Early suboptimal ART adherence was associated with missed clinical visits in HIV-infected patients in Asia
Missed clinic visits can lead to poorer treatment outcomes in HIV-infected patients. Suboptimal antiretroviral therapy (ART) adherence has been linked to subsequent missed visits. Knowing the determinants of missed visits in Asian patients will allow for appropriate counselling and intervention strategies to ensure continuous engagement in care. A missed visit was defined as having no assessments within six months. Repeated measures logistic regr…
Lingering sex and age disparities in dolutegravir uptake among adults with HIV
INTRODUCTION: Since July 2019, the WHO has recommended dolutegravir (DTG)-based regimens as preferred first-line antiretroviral therapy (ART) for adults and adolescents living with HIV (DTG-for-All), a reversal of a 2018 safety alert on use of DTG-based regimens by women of reproductive age (WRA). We examined sex and age disparities in DTG uptake before and after DTG-for-All in the International epidemiology Databases to Evaluate AIDS. METHODS: W…
HIV/AIDS drug development and treatment (2 works) · HIV/AIDS Research and Interventions (2 works) · Antiretroviral therapy (1 works) · Cohort study (1 works) · Cumulative incidence (1 works) · Dolutegravir (1 works) · Epidemiology (1 works) · Family medicine (1 works) · HIV Research and Treatment (1 works) · HIV-related health complications and treatments (1 works)